UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Hematology, 2017-12, Vol.2017 (1), p.565-577

Ferreri, Andrés José María

2017

Link zum Volltext

Verfügbarkeit prüfen

Primary central nervous system marginal zone lymphoma

British journal of haematology, 2024-01, Vol.204 (1), p.31-44

2024

Link zum Volltext

Verfügbarkeit prüfen

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

Frontiers in oncology, 2021-11, Vol.11, p.730194-730194

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma

International journal of radiation oncology, biology, physics, 2001-07, Vol.50 (3), p.651-658

2001

Link zum Volltext

Verfügbarkeit prüfen

Current uses of radiation therapy in patients with primary CNS lymphoma

Expert review of anticancer therapy, 2013-11, Vol.13 (11), p.1327-1337

2013

Link zum Volltext

Verfügbarkeit prüfen

Consolidation Radiotherapy in Primary Central Nervous System Lymphomas: Impact on Outcome of Different Fields and Doses in Patients in Complete Remission After Upfront Chemotherapy

International journal of radiation oncology, biology, physics, 2011-05, Vol.80 (1), p.169-175

2011

Link zum Volltext

Verfügbarkeit prüfen

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV

Hematological oncology, 2022-12, Vol.40 (5), p.846-856

2022

Link zum Volltext

Verfügbarkeit prüfen

Using immunogenetics to inform immunotherapy of lymphoid malignancies

The Lancet. Haematology, 2022-02, Vol.9 (2), p.e88-e89

2022

Link zum Volltext

Verfügbarkeit prüfen

Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B‐Cell Lymphoma

The oncologist (Dayton, Ohio), 2012-06, Vol.17 (6), p.838-846

2012

Link zum Volltext

Verfügbarkeit prüfen

Target delineation in post-operative radiotherapy of brain gliomas: Interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans

Radiotherapy and oncology, 2005-05, Vol.75 (2), p.217-223

2005

Link zum Volltext

Verfügbarkeit prüfen

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R‐POLA‐MINI‐CHP AND R‐MINI‐CHOP

HemaSphere, 2023-08, Vol.7 (S3), p.e91359ec-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Primary central nervous system lymphoma

Critical reviews in oncology/hematology, 2017-05, Vol.113, p.97-110

2017

Link zum Volltext

Verfügbarkeit prüfen

Seeking solutions to old problems in elderly patients with lymphoma

The Lancet. Haematology, 2018-06, Vol.5 (6), p.e235-e236

María Ferreri, Andrés José

2018

Link zum Volltext

Verfügbarkeit prüfen

Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type

Current research in translational medicine, 2021-10, Vol.69 (4), p.103313-103313, Article 103313

2021

Link zum Volltext

Verfügbarkeit prüfen

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

Blood advances, 2022-01, Vol.6 (1), p.327-338

2022

Link zum Volltext

Verfügbarkeit prüfen

Salvage Therapy With Temozolomide in an Immunocompetent Patient With Primary Brain Lymphoma

JNCI : Journal of the National Cancer Institute, 2000-04, Vol.92 (7), p.575-576

2000

Link zum Volltext

Verfügbarkeit prüfen

S221: LONG‐TERM RESULTS OF THE FIL MCL0208 TRIAL COMPARING LENALIDOMIDE MAINTENANCE (LEN) VS OBSERVATION (OBS) AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MANTLE CELL LYMPHOMA (MCL)

HemaSphere, 2023-08, Vol.7 (S3), p.e8994203-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Consolidation Radiotherapy for a Rare Case of Extranodal Mucosa-Associated Lymphoid Tissue Non-Hodgkin's Lymphoma Synchronous with Prostate Adenocarcinoma

Tumori, 2010-05, Vol.96 (3), p.498-502

2010

Link zum Volltext

Verfügbarkeit prüfen

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

HemaSphere, 2023-08, Vol.7 (S3), p.e2454568-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic management of refractory or relapsed primary central nervous system lymphomas

Annals of hematology, 2001-11, Vol.80 Suppl 3 (S3), p.B113-B118

2001

Link zum Volltext

Verfügbarkeit prüfen

Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation

International journal of radiation oncology, biology, physics, 2002-02, Vol.52 (2), p.483-488

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(26)
Hematology
(16)
Oncology
(14)
Adult
(12)
Aged
(12)
Male
(12)
Female
(11)
Middle Aged
(11)
Treatment Outcome
(10)
Lymphoma
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Biological And Medical Sciences
(5)
Central Nervous System Neoplasms - Radiotherapy
(5)
Combined Modality Therapy
(5)
Medical Sciences
(5)
Prognosis
(5)
Retrospective Studies
(5)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents

Primary central nervous system marginal zone lymphoma

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B‐cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

CNS Prophylaxis: How Far Is Routine Practice From the Guidelines? Focus on a Nationwide Survey by the Fondazione Italiana Linfomi (FIL)

Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

Current uses of radiation therapy in patients with primary CNS lymphoma

Consolidation Radiotherapy in Primary Central Nervous System Lymphomas: Impact on Outcome of Different Fields and Doses in Patients in Complete Remission After Upfront Chemotherapy

Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV

Using immunogenetics to inform immunotherapy of lymphoid malignancies

Modulated Chemotherapy According to Modified Comprehensive Geriatric Assessment in 100 Consecutive Elderly Patients with Diffuse Large B‐Cell Lymphoma

Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease

Target delineation in post-operative radiotherapy of brain gliomas: Interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R‐POLA‐MINI‐CHP AND R‐MINI‐CHOP

Primary central nervous system lymphoma

Seeking solutions to old problems in elderly patients with lymphoma

Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study

Salvage Therapy With Temozolomide in an Immunocompetent Patient With Primary Brain Lymphoma

S221: LONG‐TERM RESULTS OF THE FIL MCL0208 TRIAL COMPARING LENALIDOMIDE MAINTENANCE (LEN) VS OBSERVATION (OBS) AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MANTLE CELL LYMPHOMA (MCL)

Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study

Consolidation Radiotherapy for a Rare Case of Extranodal Mucosa-Associated Lymphoid Tissue Non-Hodgkin's Lymphoma Synchronous with Prostate Adenocarcinoma

S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)

Therapeutic management of refractory or relapsed primary central nervous system lymphomas

Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation

Suchergebnisse filtern